Taken together, these data indicated that the expression of genes related to both innate and adaptive immunity was compromised in circulating PD‐1 (+) cells of patients with PTCL, which may lead to insufficient anti‐tumor immune activity of the host immune system and contribute to tumor immune escape. Here, PDCD1 is linked to neoplasm.